The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Svobodov A.A.

Bakulev National Medical Research Center of Cardiovascular Surgery

Krylova A.S.

Bakulev National Medical Research Center of Cardiovascular Surgery

Transcatheter pulmonary valve implantation: review of the valves approved for clinical application

Authors:

Svobodov A.A., Krylova A.S.

More about the authors

Read: 3774 times


To cite this article:

Svobodov AA, Krylova AS. Transcatheter pulmonary valve implantation: review of the valves approved for clinical application. Russian Journal of Cardiology and Cardiovascular Surgery. 2022;15(2):144‑150. (In Russ.)
https://doi.org/10.17116/kardio202215021144

Recommended articles:
Surgical treatment of infa­nts with severe form of tetralogy of Fallot. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(4):445-453
Arti­ficial inte­lligence capa­bilities in choosing surgical treatment for tetralogy of Fallot. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(5):560-565

References:

  1. McElhinney DB, Hennesen JT. The Melody valve and Ensemble delivery system for transcatheter pulmonary valve replacement Annals of the New York Academy of Sciences, Issue: Pharmaceutical Science to Improve the Human Condition: Prix Galien. 2013;1291:77-85.  https://doi.org/10.1111/nyas.12194
  2. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356: 1403-1405. https://doi.org/10.1016/s0140-6736(00)02844-0
  3. Giugno L, Faccini A, Carminati M. Percutaneous Pulmonary Valve Implantation. Korean Circ J. 2020;50(4):302-316.  https://doi.org/10.4070/kcj.2019.0291
  4. Zhou Y, Xiong T, Bai P, Chu C, Dong N. Clinical outcomes of transcatheter versus surgical pulmonary valve replacement: A meta-analysis. Thorac Dis. 2019;11(12):5343-5351. https://doi.org/10.21037/jtd.2019.11.64
  5. Garay F, Webb J, Hijazi ZM. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: First report in a human patient. Catheter Cardiovasc Interv. 2006;67(5):659-662.  https://doi.org/10.1002/ccd.20753
  6. Voevodin AB, Allenov AA, Bazylev VV. Valve-in-valve transcatheter implantation of the «MEDLAB-CT» prosthesis. Angiology and Vascular Surgery. 2020;26(1):135-137. (In Russ.).
  7. Demkow M, Biernacka EK, Spiewak M, et al. Percutaneous pulmonary valve implantation preceded by routine presenting with a bare metal stent. Catheter Cardiovasc Interv. 2011;77:381-389.  https://doi.org/10.1002/ccd.22700
  8. Sizarov A, Boudjemline Y. Novel materials and devices in the transcatheter management of congenital heart diseases — the future comes slowly (part 3). Arch Cardiovasc Dis. 2016;109(5):348-358.  https://doi.org/10.1016/j.acvd.2016.01.005
  9. Bertels RA, Blom NA, Schalij MJ. Edwards SAPIEN transcatheter heart valve in native pulmonary valve position. Heart. 2010;96(9):661.  https://doi.org/10.1136/hrt.2009.189944
  10. Martin MH, Shahanavaz S, Peng LF, et al. Percutaneous transcatheter pulmonary valve replacement in children weighing less than 20 kg. Catheterization and Cardiovascular Intervention. 2018;91(3):485-494. First published: 29 November 2017. https://doi.org/10.1002/ccd.27432
  11. Khambadkone S, Coats L, Taylor A, et al. Transcatheter pulmonary valve implantation in humans: Initial results in 59 consecutive patients. Circulation. 2005;112:1189-1197. https://doi.org/10.1016/j.accreview.2005.11.088
  12. Lee SY. The Significance of Self-Expandable Stents in Patients with Congenital Heart Disease in Current Era. Korean Circ J. 2019;49(10):943-944.  https://doi.org/10.4070/kcj.2019.0201
  13. Cao QL, Kenny D, Zhou D, et al. Early Clinical Experience with a Novel Self-Expanding Percutaneous Stent-Valve in the Native Right Ventricular Outflow Tract. Catheterization and Cardiovascular Interventions. 2014;84(7):1131-1137. https://doi.org/10.1002/ccd.25544
  14. Hainstock MR, Marshall AC, Lock JE, McElhinney DB. Angioplasty of obstructed homograft conduits in the right ventricular outflow tract with ultra-non-compliant balloons: Assessment of therapeutic efficacy and conduit tears. Circ Cardiovasc Interv. 2013;6:671-679.  https://doi.org/10.1161/circinterventions. 112.000073
  15. Morgan G, Prachasilchai P, Promphan W, et al. Medium-term results of percutaneous pulmonary valve implantation using the Venus P-valve: international experience. Euro Intervention. 2019;14:1363-1370. https://doi.org/10.4244/EIJ-D-18-00299
  16. Morgan GJ, Sivakumar K, Promphan W, et al. Early clinical experience with the straight design of Venus P-valve in dysfunctional right ventricular outflow tracts. Catheter Cardiovasc Interv. 2020;96(6):653-6591. https://doi.org/10.1002/ccd.28819
  17. Kim GB, Song MK, Bae EJ, et al. Successful Feasibility Human Trial of a New Self-Expandable Percutaneous Pulmonary Valve (Pulsta Valve) Implantation Using Knitted Nitinol Wire Backbone and Trileaflet α-Gal-Free Porcine Pericardial Valve in the Native Right Ventricular Outflow Tract. Circ Cardiovasc Interv. 2018;11(6):e006494. https://doi.org/10.1161/CIRCINTERVENTIONS.118.006494
  18. Kim AY, Jung JW, Jung SY, et al. Early Outcomes of Percutaneous Pulmonary Valve Implantation with Pulsta and Melody Valves: The First Report from Korea. J Clin Med. 2020;9(9):2769. https://doi.org/10.3390/jcm9092769
  19. Benson LN, Gillespie MJ, Bergersen L, et al. Three-Year Outcomes From the Harmony Native Outflow Tract Early Feasibility Study Circ Cardiovasc Interv. 2020;13(1):e008320. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008320
  20. Cheatham JP. Primary Outcomes of the Harmony Transcatheter Pulmonary Valve Pivotal Trial SCAI 2020 Scientific Sessions Virtual Conference, May 14-16, 2020.
  21. Armstrong AK, Berger F, Jones TK, et al. Association between patient age at implant and outcomes after transcatheter pulmonary valve replacement in the multicenter Melody valve trials. Catheter Cardiovasc Interv. 2019;94(4):607-617.  https://doi.org/10.1002/ccd.28454
  22. Alkashkari W, Albugami S, Abbadi M, et al. Transcatheter pulmonary valve replacement in pediatric patients. Expert Review of Medical Devices. 2020;17(6):541-554.  https://doi.org/10.1080/17434440.2020.1775578
  23. Holoshitz N, Hijazi Rush ZM. Transcatheter pulmonary valve replacement: valves, techniques of implantation and outcomes. Interventional Cardiology. 2013;5:4:465-477.  https://doi.org/10.2217/ica.13.36
  24. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation. 2010;122:507-516.  https://doi.org/10.1161/circulationaha.109.921692
  25. McElhinney DB, Sondergaard L, Armstrong AK, et al. Endocarditis After Transcatheter Pulmonary Valve Replacement Clinical Trial. J Am Coll Cardiol. 2018;72:22:2717-2728. https://doi.org/10.1016/j.jacc.2018.09.039
  26. Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation impact of evolving technology and learning curve on clinical outcomes. Circulation. 2008;117(15):1964-1972. https://doi.org/10.1161/circulationaha.107.735779

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.